Tropical Journal of Pharmaceutical Research
Pharmacotherapy Group, Faculty of Pharmacy, University of Benin, Benin City, Nigeria
Vol. 9, No. 6, 2010, pp. 595-603
Bioline Code: pr10072
Full paper language: English
Document type: Review Article
Document available free of charge
Tropical Journal of Pharmaceutical Research, Vol. 9, No. 6, 2010, pp. 595-603
© Copyright 2010 Tropical Journal of Pharmaceutical Research.
Arformoterol Tartrate: A Review of Pharmacology, Analysis and Clinical Studies|
Pahwa, Rakesh; Soni, Vijay; Sharma, Prabodh Chander; Kumar, Vipin & Kohli, Kanchan
This article is a review of the therapeutic significance of arformoterol tartrate, a new generation β2 adrenergic agonist bronchodilator available in a nebulized form. Arformoterol is well absorbed through the lungs when administered via a standard jet nebulizer and is useful in long-term maintenance therapy of bronchoconstriction in chronic obstructive pulmonary disease (COPD). Much clinical evidence suggest the potentially enhanced efficacy of this drug in the treatment of COPD including chronic bronchitis and emphysema. Various hyphenated analytical methodologies have also been employed for the determination and quantification of arformoterol. This review provides an updated account on the pharmacology, pharmacokinetics, clinical studies, analytical techniques, drug-drug interactions, contraindications, and therapeutic applications of arformoterol tartrate.
Arformoterol tartrate, Adrenergic agonist, Bronchodilator, COPD.
Alternative site location: http://www.tjpr.org